Backlash to massive drug price slash for items on appeal.

The drug industry sharply resists against the government's massive price slashes particularly for the items that earlier raised appeals, claiming that the government decision was measured without paying any consideration to the real market practice, and therefore the industry said they would take an administrative litigation.

The MOHW has recently reduced overall drug prices by 6.18% on aver...